PERAN SISTEM FlBRINOL1S1S PADA BERBAGAI PROSES FISIOLOGIS DAN PATOLOGIS

作者: Anak Agung , Gde Budhiarta

DOI:

关键词:

摘要: Plasminogen can be converted to plasmin either by t-PA or u-PA. A dual role for these pathways is now well established where involved in fibrin homeostasis and u-PA primarily cell migration tissue remodelling. Using this mechanism thrombolytic terapy of myocardial infarction some other thromboembolic diseases have been introduced. Thrombolytic therapy could improved earlier accelerated treatment, the used plasminogen activator with increased potency such as reteplase, tenetecplase staphylokinase use more specific potent anticoagulant antiplatelet agents. Increased activity matrix metalloproteinases (MMPs) has implicated numerous disease processes, including tumor growth metastases, arthritis, periodontal disease. It becoming increasingly clear that extracelluler degradation M Ps also pathogenesis cardiovascular disease, atherosclerosis, restenosis, dilated cardiomyapathi,and infarction. Administration synthetic MMP inhibitor experimental animal models of; significantly inhibits progression respectivelyatherosclerotic lesion formation, neointima left ventricular remodeling, pump dysfunction, infarc healing.

参考文章(13)
Petr Klement, Peng Liao, Laszlo Bajzar, A novel approach to arterial thrombolysis. Blood. ,vol. 94, pp. 2735- 2743 ,(1999) , 10.1182/BLOOD.V94.8.2735.420K30_2735_2743
Peter Carmeliet, Désiré Collen, Molecular analysis of blood vessel formation and disease American Journal of Physiology-heart and Circulatory Physiology. ,vol. 273, ,(1997) , 10.1152/AJPHEART.1997.273.5.H2091
Aaron R. Folsom, Nena Aleksic, Eunsik Park, Veikko Salomaa, Harinder Juneja, Kenneth K. Wu, Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 21, pp. 611- 617 ,(2001) , 10.1161/01.ATV.21.4.611
V. Salomaa, V. Stinson JD, J.D. Kark, A.R. Folsom, C.E. Davis, K.K. Wu, Association of Fibrinolytic Parameters With Early Atherosclerosis The ARIC Study Circulation. ,vol. 91, pp. 284- 290 ,(1995) , 10.1161/01.CIR.91.2.284
Andrew D Blann, Martin J Landray, Gregory YH Lip, ABC of antithrombotic therapy: An overview of antithrombotic therapy BMJ. ,vol. 325, pp. 762- 765 ,(2002) , 10.1136/BMJ.325.7367.762
P. J. DECLERCK, I. JUHAN-VAGUE, J. FELEZ, B. WIMAN, Pathophysiology of fibrinolysis Journal of Internal Medicine. ,vol. 236, pp. 425- 432 ,(1994) , 10.1111/J.1365-2796.1994.TB00820.X